Company intelligence / Profile preview

Yumlish

Dallas, Texas, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Yumlish is a digital health company that provides a culturally competent diabetes prevention and management program. The platform utilizes artificial intelligence to offer personalized nutrition and lifestyle coaching tailored to the cultural heritage and socioeconomic factors of its users. By addressing the unique dietary habits and health disparities of minority populations, Yumlish aims to improve health outcomes and reduce the cost of care for chronic conditions like type 2 diabetes. The company partners with health plans and employers to deliver its evidence-based, CDC-recognized program.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Non-pharmacological therapyDigital health platform
Industry: Digital Health Medical Devices

Partnerships

TechstarsMassChallengeAmerican Diabetes Association

Beyond the preview

Go deeper on Yumlish.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yumlish.

Explore the full profile